Astrivax
4 known investors
Astrivax develops virus-targeted immunotherapies using its Launch-iT platform to eliminate cancer-causing viruses before they lead to disease, with an initial focus on HPV-driven cancers. The company targets an oncology therapeutic space for people at risk of virus-driven cancers.
BiotechHealthtech
Investors · 4
Frequently asked questions
- What does Astrivax do?
- Astrivax develops virus-targeted immunotherapies using its Launch-iT platform to eliminate cancer-causing viruses before they lead to disease, with an initial focus on HPV-driven cancers. The company targets an oncology therapeutic space for people at risk of virus-driven cancers.
- Who are Astrivax's investors?
- Astrivax's investors include Fund+, Korys, PMV, V-Bio Ventures.